Euroapi SAS
PAR:EAPI
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Euroapi SAS
Intangible Assets
Euroapi SAS
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
Euroapi SAS
PAR:EAPI
|
Intangible Assets
€38.1m
|
CAGR 3-Years
12%
|
CAGR 5-Years
59%
|
CAGR 10-Years
N/A
|
|
|
Sanofi SA
PAR:SAN
|
Intangible Assets
€67.6B
|
CAGR 3-Years
46%
|
CAGR 5-Years
30%
|
CAGR 10-Years
19%
|
|
|
Ipsen SA
PAR:IPN
|
Intangible Assets
€2.3B
|
CAGR 3-Years
18%
|
CAGR 5-Years
13%
|
CAGR 10-Years
36%
|
|
|
Vetoquinol SA
PAR:VETO
|
Intangible Assets
€134.7m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
20%
|
CAGR 10-Years
11%
|
|
|
Virbac SA
PAR:VIRP
|
Intangible Assets
€237.6m
|
CAGR 3-Years
15%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-4%
|
|
|
Medincell SA
PAR:MEDCL
|
Intangible Assets
€3m
|
CAGR 3-Years
20%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
Euroapi SAS
Glance View
EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,342 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.
See Also
What is Euroapi SAS's Intangible Assets?
Intangible Assets
38.1m
EUR
Based on the financial report for Dec 31, 2024, Euroapi SAS's Intangible Assets amounts to 38.1m EUR.
What is Euroapi SAS's Intangible Assets growth rate?
Intangible Assets CAGR 5Y
59%
Over the last year, the Intangible Assets growth was 11%. The average annual Intangible Assets growth rates for Euroapi SAS have been 12% over the past three years , 59% over the past five years .
